益气化瘀汤治疗冠心病心绞痛痰瘀互阻证的临床研究

Clinical Study on Yiqi Huayu Decoction in the Treatment of Coronary Heart Disease with Angina Pectoris with Phlegm and Blood Stasis Syndrome

目的探析在治疗冠心病心绞痛痰瘀互阻证中益气化瘀汤所能发挥的临床价值。方法选取本院2016年2月至2017年2月接收的68例冠心病心绞痛痰瘀互阻证患者为研究对象,采用数字表分组法,随机分为两组,即治疗组与对照组。两组均予西药常规治疗,治疗组再给予益气化瘀汤治疗,观察并对比两种不同治疗方法在治疗冠心病心绞痛痰瘀互阻证的临床价值。结果两组患者在接受治疗后,在治疗有效率方面,对照组与治疗组之间存在显著差异,即P<0.05;在血液黏稠度的控制方面,治疗组与对照组患者在血液流变学的指标上也存在着明显差异,即P<0.05。结论对于冠心病心绞痛痰瘀互阻证的患者而言,治疗组有效控制患者的血液黏稠度,缓解胸闷、心悸等不良症状,益气化瘀汤临床疗效确切。

Objective To explore the clinical value of Yiqi Huayu Decoction in the treatment of coronary heart disease and angina pectoris with phlegm and blood stasis syndrome. Methods From February 2016 to February 2017, 68 cases of coronary heart disease angina pectoris patients with phlegm and blood stasis syndrome were selected as the research object, and were divided into two groups randomly, namely the treatment group and the control group. The two groups were treated with conventional western medicine, and the treatment group was given Yiqi Huayu Decoction. The clinical value of two different treatment methods in the treatment of coronary heart disease angina pectoris with phlegm and blood stasis syndrome was observed and compared. Results Two groups of patients after treatment, in the treatment efficiency, there were significant differences between the control group and treatment group, between P〈0.05; in the control of blood viscosity, the treatment group and the control group of patients there are also significant differences in blood rheology indexes, namely P〈0.05. Conclusion For patients with coronary heart disease angina pectoris phlegm and blood stasis syndrome, the treatment group can effectively control the blood viscosity, relieve chest distress, palpitations and other adverse symptoms, Yiqi Huayu Decoction clinical curative effect is exact.